Donna Ambrosino
Director/Miembro de la Junta en CLOVER BIOPHARMACEUTICALS, LTD. .
Fortuna: 6 925 $ al 30/04/2024
Perfil
Donna M.
Ambrosino is a professional with a doctorate degree from Dartmouth Medical School and an undergraduate degree from Harvard University.
She is currently a Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2022.
Previously, she worked as the Chief Medical Officer at Visterra, Inc. from 2012 to 2014.
She also held the position of Associate Professor at Harvard Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2024 | 156 992 ( 0.01% ) | 6 925 $ | 30/04/2024 |
Cargos activos de Donna Ambrosino
| Empresas | Cargo | Inicio |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director/Miembro de la Junta | 17/06/2022 |
Antiguos cargos conocidos de Donna Ambrosino.
| Empresas | Cargo | Fin |
|---|---|---|
| VISTERRA INC | Director Técnico/Científico/I+D | 01/01/2014 |
| Harvard Medical School | Corporate Officer/Principal | - |
Formación de Donna Ambrosino.
| Dartmouth Medical School | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Donna Ambrosino
